Prospective Study of Triple Combination Chemotherapy Consisting of Paclitaxel, S-1, and 24-Hour Infusion of Cisplatin (PSC) for Inoperable Highly Advanced Gastric Cancer

doi 10.5772/20268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech